Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study-Reference-Cited by-同舟云学术

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study

Published:2016-11 Issue:4 Volume:96 Page:759-769
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pommier Pascal,Chabaud Sylvie,Lagrange Jean-Leon,Richaud Pierre,Le Prise Elisabeth,Wagner Jean-Philippe,Azria David,Beckendorf Veronique,Suchaud Jean-Philippe,Bernier Valerie,Perol David,Carrie Christian

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01;Pommier;J Clin Oncol,2007

2. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions;Lawton;Int J Radiat Oncol Biol Phys,2007

3. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer;Roach;Int J Radiat Oncol Biol Phys,1994

4. Nonparametric estimation from incomplete observations;Kaplan;J Am Stat Assoc,1958

5. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples;Peto;Br J Cancer,1977

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials;Clinical and Translational Radiation Oncology;2024-11

2. Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study;Clinical and Translational Radiation Oncology;2024-09

3. Pushing the Borders: One at a Time. Reply to C. Onal, A. Elmaliy, P. Hurmuz's Letter to Editor Re: Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines in Regard to Singh et al.;Clinical Oncology;2024-09

4. Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate Cancer Study 5, a Groupe de Radio-oncologie Génito-urinaire du Quebec–led Phase 3 Trial;European Urology;2024-09

5. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25